These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33807295)

  • 41. Determinants of quality of life and psychological status in adults with psoriasis.
    Kwan Z; Bong YB; Tan LL; Lim SX; Yong ASW; Ch'ng CC; Tan MP; Ismail R
    Arch Dermatol Res; 2018 Jul; 310(5):443-451. PubMed ID: 29687328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life in patients with psoriasis in northern Taiwan.
    Lin TY; See LC; Shen YM; Liang CY; Chang HN; Lin YK
    Chang Gung Med J; 2011; 34(2):186-96. PubMed ID: 21539761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients.
    Kim GE; Seidler E; Kimball AB
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):249-254. PubMed ID: 24684416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute and relative psoriasis area and severity index (PASI) treatment goals and their association with health-related quality of life.
    Gerdes S; Körber A; Biermann M; Karnthaler C; Reinhardt M
    J Dermatolog Treat; 2020 Aug; 31(5):470-475. PubMed ID: 32202943
    [No Abstract]   [Full Text] [Related]  

  • 46. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
    Mørk C; Wahl A; Moum T
    Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
    Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
    Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relaxation therapy in the management of psoriasis.
    Neerackal RJ; Abdul Latheef EN; Sukumarakurup S; Jafferany M
    Dermatol Ther; 2020 Nov; 33(6):e14030. PubMed ID: 32683732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of quality of life in patients with psoriasis: a study from Serbia.
    Milčić D; Janković S; Vesić S; Milinković M; Janković J
    Int J Dermatol; 2015; 54(5):523-8. PubMed ID: 24738764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies.
    Armstrong AW; Reich K; Foley P; Han C; Song M; Shen YK; You Y; Papp KA
    Am J Clin Dermatol; 2019 Feb; 20(1):155-164. PubMed ID: 30417277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depressive symptoms among mothers of children with psoriasis-A case-control study.
    Żychowska M
    Pediatr Dermatol; 2020 Nov; 37(6):1038-1043. PubMed ID: 33010067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
    Fernández-Torres RM; Pita-Fernández S; Fonseca E
    Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of life in psoriasis: a study from south India.
    Rakhesh SV; D'Souza M; Sahai A
    Indian J Dermatol Venereol Leprol; 2008; 74(6):600-6. PubMed ID: 19171982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The factors affecting quality of life in Thai psoriasis patients.
    Thakolwiboon S; Upala S; Geeratragool T; Benjatikul N; Uathaya M; Tripipitsiriwat A; Jiranapakul S; Chutinimitkul B; Wongpraparut C; Kulthanan K; Jiamton S
    J Med Assoc Thai; 2013 Oct; 96(10):1344-9. PubMed ID: 24350418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate-to-severe plaque-type psoriasis patients treated with infliximab in routine care settings of Greece.
    Petridis A; Panagakis P; Moustou E; Vergou T; Kallidis P; Mandekou-Lefaki I; Chaidemenos G; Sotiriadis D; Alexopoulou G; Haratsis Y; Antoniou C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):768-775. PubMed ID: 29356149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.
    Tsai TF; Song M; Shen YK; Schenkel B; Choe YB; Kim NI; Lee JH; Lee JH; Song HJ; Youn JI;
    J Drugs Dermatol; 2012 Aug; 11(8):943-9. PubMed ID: 22859239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.